Article Text

other Versions


Reducing tobacco-related harm: FDA’s proposed product standard for smokeless tobacco
  1. Micah L Berman1,
  2. Dorothy K Hatsukami2
  1. 1College of Public Health & Moritz College of Law, Ohio State University, Columbus, Ohio, USA
  2. 2Department of Psychiatry & Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
  1. Correspondence to Micah L Berman, College of Public Health & Moritz College of Law, Ohio State University, 1148 Neil Avenue, Columbus, OH 43210, USA; berman.31{at}


This Special Communication discusses the Food and Drug Administration's (FDA's) proposed rule that would limit N-nitrosonornicotine (NNN) levels in smokeless tobacco products. It argues that finalising and implementing this first 'product standard' would mark a significant step forward in the FDA's efforts to reduce tobacco-related harms.

  • public policy
  • Non-cigarette tobacco products
  • harm reduction

Statistics from


  • Contributors The authors contributed equally to the development of this article.

  • Funding Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers U19CA157345 and K07CA197221.

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.